Single photon emission computed tomography (SPECT) is an imaging study that uses radioactive materials injected through a vein that will pass into the brain generating a high-resolution brain image.
SPECT is used to diagnose head trauma, epilepsy, dementia, and cerebrovascular disease. Development of a radiotracer called Tc99m label has increased the resolution of brain images generated from SPECT. The images yield very accurate spatial and contrast resolutions. The resulting sharp images enable the clinician to visualize very small structures within the brain. The accuracy of SPECT brain images makes it a very useful clinical and research tool.
Clinically, SPECT is useful for diagnosing the following disease states:
As a research tool, SPECT imaging seems to be sensitive tool to measure blood flow through the brain (cerebral blood flow), in persons who have psychological disorder such as obsessive-compulsive disorder(higher blood flow) and alcoholism (lower blood flow).
Other dianostic indications and procedures are similar to other imaging studies such as computed tomography, magnetic resonance imaging, and PET.
Busatto, Geraldo, F. "Regional cerebral blood flow abnormalities in early-onset obsessive-compulsive disorder: an exploratory SPECT study." Journal of the American Academy of Child and Adolescent Psychiatry43, no. 3. (March 2001): 347.
Gansler, David A. "Hypoperfusion of inferior frontal brain regions in abstinent alcoholics: a pilot SPECT study." Journal of Studies on Alcohol61, no. 1 (January 2000):32.
Van Heertum, R. "Single photon emission, CT, and positron emission tomography in the evaluation of neurologic disease." Radiologic Clinics of North America39, no. 5 (September 2001).
Laith Farid Gulli, M.D. Alfredo Mori, M.D. Jean Suvan, B.Sc., R.D.H.
The following comments are not guaranteed to be that of a trained medical professional. Please consult your physician for advice.